Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Human allogeneic bone-marrow-derived osteoblastic cells

EU orphan designation number: EU/3/15/1533   
Active ingredient: Human allogeneic bone-marrow-derived osteoblastic cells
Indication: Treatment of osteogenesis imperfecta
Sponsor: Bone Therapeutics SA
rue Auguste Piccard 37, 6041 Gosselies, Belgique

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/08/2015 Orphan designation EMA/OD/053/15 (2015)5769 of 10/08/2015
13/04/2016 Change of name and/or address of sponsor